{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:09:27Z","timestamp":1791320967080,"version":"4.3.1"},"reference-count":45,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T00:00:00Z","timestamp":1357516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Enterocyte damage is the hallmark of coeliac disease (\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      ) resulting in malabsorption. Little is known about the recovery of enterocyte damage and its clinical consequences. Serum intestinal fatty acid binding protein (I\u2010\n                      <jats:styled-content style=\"fixed-case\">FABP<\/jats:styled-content>\n                      ) is a sensitive marker to study enterocyte damage.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      To evaluate the severity of enterocyte damage in adult\u2010onset\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      and its course upon a gluten\u2010free diet (\n                      <jats:styled-content style=\"fixed-case\">GFD<\/jats:styled-content>\n                      ). Furthermore, the correlation among enterocyte damage,\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      autoantibodies and histological abnormalities during the course of disease is studied.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Serum I\u2010\n                      <jats:styled-content style=\"fixed-case\">FABP<\/jats:styled-content>\n                      levels were determined in 96 biopsy\u2010proven adult\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      patients and in 69 patients repeatedly upon a\n                      <jats:styled-content style=\"fixed-case\">GFD<\/jats:styled-content>\n                      . A total of 141 individuals with normal antitissue transglutaminase antibody (\n                      <jats:styled-content style=\"fixed-case\">IgA<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">tTG<\/jats:styled-content>\n                      ) levels served as controls. I\u2010\n                      <jats:styled-content style=\"fixed-case\">FABP<\/jats:styled-content>\n                      levels were related to the degree of villous atrophy (Marsh grade) and IgA\u2010\n                      <jats:styled-content style=\"fixed-case\">tTG<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      I\u2010\n                      <jats:styled-content style=\"fixed-case\">FABP<\/jats:styled-content>\n                      levels were elevated in untreated\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      (median 691\u00a0pg\/mL) compared with controls (median 178\u00a0pg\/mL,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a00.001) and correlated with Marsh grade (\n                      <jats:italic>r<\/jats:italic>\n                      \u00a0=\u00a00.265,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a00.05) and IgA\u2010\n                      <jats:styled-content style=\"fixed-case\">tTG<\/jats:styled-content>\n                      (\n                      <jats:italic>r<\/jats:italic>\n                      \u00a0=\u00a00.403,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a00.01). Upon a\n                      <jats:styled-content style=\"fixed-case\">GFD<\/jats:styled-content>\n                      serum levels decreased significantly, however, not within the range observed in controls, despite the common observed normalisation of IgA\u2010\n                      <jats:styled-content style=\"fixed-case\">tTG<\/jats:styled-content>\n                      levels and Marsh grade.\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      patients with elevated I\u2010\n                      <jats:styled-content style=\"fixed-case\">FABP<\/jats:styled-content>\n                      levels nonresponding to\n                      <jats:styled-content style=\"fixed-case\">GFD<\/jats:styled-content>\n                      showed persistent histological abnormalities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Enterocyte damage assessed by serum I\u2010\n                      <jats:styled-content style=\"fixed-case\">FABP<\/jats:styled-content>\n                      correlates with the severity of villous atrophy in\n                      <jats:styled-content style=\"fixed-case\">coeliac disease<\/jats:styled-content>\n                      at the time of diagnosis. Although enterocyte damage improves upon treatment, substantial enterocyte damage persists despite absence of villous atrophy and low IgA\u2010\n                      <jats:styled-content style=\"fixed-case\">tTG<\/jats:styled-content>\n                      levels in the majority of cases. Elevated I\u2010\n                      <jats:styled-content style=\"fixed-case\">FABP<\/jats:styled-content>\n                      levels nonresponding to\n                      <jats:styled-content style=\"fixed-case\">gluten\u2010free diet<\/jats:styled-content>\n                      are indicative of histological abnormalities and warrant further evaluation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/apt.12194","type":"journal-article","created":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T07:13:39Z","timestamp":1357542819000},"page":"482-490","source":"Crossref","is-referenced-by-count":191,"title":["Serum I\u2010\n                    <scp>FABP<\/scp>\n                    as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies"],"prefix":"10.1111","volume":"37","author":[{"given":"M. P. M.","family":"Adriaanse","sequence":"first","affiliation":[{"name":"Department of Paediatrics &amp; Nutrition and Toxicology Research Institute Maastricht (NUTRIM) Maastricht University Medical Centre Maastricht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"Tack","sequence":"additional","affiliation":[{"name":"Small Bowel Unit Department of Gastroenterology and Hepatology VU University Medical Centre Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Lima","family":"Passos","sequence":"additional","affiliation":[{"name":"Department of Methodology and Statistics Maastricht University Maastricht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G. M. C.","family":"Damoiseaux","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Immunology Maastricht University Medical Centre Maastricht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. W. J.","family":"Schreurs","sequence":"additional","affiliation":[{"name":"Department of Pathology VU University Medical Centre Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"van Wijck","sequence":"additional","affiliation":[{"name":"Department of General Surgery Maastricht University Medical Centre Maastricht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. G.","family":"Riedl","sequence":"additional","affiliation":[{"name":"Department of Pathology Maastricht University Medical Centre Maastricht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A. M.","family":"Masclee","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology Maastricht University Medical Centre Maastricht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. A.","family":"Buurman","sequence":"additional","affiliation":[{"name":"Department of General Surgery Maastricht University Medical Centre Maastricht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J. J.","family":"Mulder","sequence":"additional","affiliation":[{"name":"Small Bowel Unit Department of Gastroenterology and Hepatology VU University Medical Centre Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C. E.","family":"Vreugdenhil","sequence":"additional","affiliation":[{"name":"Department of Paediatrics &amp; Nutrition and Toxicology Research Institute Maastricht (NUTRIM) Maastricht University Medical Centre Maastricht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,1,7]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071600"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.23"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.6.811"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1309\/UV54-BHP3-A66B-0QUD"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.10"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1309\/EVXT-851X-WHLC-RLX9"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03992.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01283.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200311000-00007"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07284.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200203000-00017"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01838.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03501.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.128934"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0b013e3180644e32"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8566578"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2004.09.001"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31819194b0"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-009-0608-y"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.627447"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.10.004"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91819-P"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.983_f.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2005.02.001"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02481-8"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1019926121972"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1994.tb06018.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2005.117"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00170-7"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.111.018093"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.41.8.886"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.313"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(03)00457-2"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.3109\/01913128409018588"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2007.02621.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MCG.0b013e3181b64557","article-title":"Usefulness of small\u2010bowel mucosal transglutaminase\u20102 specific autoantibody deposits in the diagnosis and follow\u2010up of celiac disease","volume":"44","author":"Koskinen O","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-0813-5"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04053.x"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310003318"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-925178"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30253"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2670"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1992.tb02881.x"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03820.x"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03311.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.12194","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.12194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T11:45:52Z","timestamp":1700653552000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.12194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1111\/apt.12194"],"URL":"https:\/\/doi.org\/10.1111\/apt.12194","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,7]]}}}